|
More site info...
Biotechnology | Forum profile
|
|
Forum profile page for Biotechnology on http://siliconinvestor.advfn.com.
This report page is the aggregated overview from a single forum: Biotechnology, located on the Message Board at http://siliconinvestor.advfn.com.
This forum profile page summarizes the general forum statistics such as: Users Activity, Forum Activity, and Top Authors, which are reported in either a table or graph below for a given reporting time period.
Additional forum profile information for "Biotechnology" on the Message Board at http://siliconinvestor.advfn.com is also shown in the following ways:
1) Latest Active Threads
2) Hot Threads for Last Week
Warning: These statistics are generated using 'best efforts' and can experience delays and reporting errors at times. Please note that such statistics do not constitute a forum's popularity and/or exact posting volumes at any given reporting period.
|
|
|
|
|
Posting activity on Biotechnology:
|
|
Week
|
Month
|
3 Months
|
|
Threads:
|
267
|
1,158
|
3,806
|
|
Post:
|
267
|
1,159
|
3,807
|
|
|
Biotechnology Posting activity graph:
|
Top authors during last week:
user's latest post:
Biotech Valuation
Published (2009-07-08 15:03:00)
Dow Jones NewsPlus access thru Thursday: http://www.djnewsplus.com/nae/al?rnd=%2FCSZlhgw%2BEZhardEg8KwlQ%3D%3D
user's latest post:
MEDX ... anybody following?
Published (2009-07-08 15:27:00)
>>It is the indication (and result) that matters<< I appreciate that. My point was that shareholders sold ABGX for a couple of billion three years ago, and in one morning it has added $9bn to AMGN's value. Plenty of 'indications' in the MEDX pipeline. Of course, the 'results' are moot - but then again, I'm not claiming it's worth $9bn. Just that the denosumab news provides a...
user's latest post:
Provectus Pharmaceuticals Inc.
Published (2009-07-08 18:00:00)
You're correct. I don't think they can manage do all of those on this amount. The figure might increase towards the end of the year if there are warrant exercises and/or they manage to strike a deal for the PH-10 business. At the very least, the cash balance gives them some leeway to operate and negotiate.
user's latest post:
Biotech Valuation
Published (2009-07-08 17:11:00)
>...not having any gauge as to what is the normal amount of daily trains traversing the area, the thing that was obvious was the total lack of trains transporting finished goods. 95% of the trains were carrying grain, or in the case of Wyoming…….coal.< Were the trains traveling westbound or eastbound? In the western half of the US, most trains carrying finished are moving eastbound while most trains carrying grain are moving...
user's latest post:
Arena Pharmaceuticals (ARNA)
Published (2009-07-08 18:42:00)
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock SAN DIEGO, July 8, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today the pricing of its public offering of 12,500,000 shares of its common stock at a public offering price of $4.17 per share. All of the shares are being offered by Arena. The gross proceeds to Arena, before expenses, from the sale of the shares are expected to be...
user's latest post:
Immunomedics (IMMU) - moderated
Published (2009-07-08 15:40:00)
I don't know of anything "official" with regard to the release of the dosing trial data. I did see an E-mail from UCB IR to someone I know who had E-mailed them and it said they expected to have, and release, data from the dosing trial "Early in the third quarter". That would cause most to think "July", but it doesn't have to be.
user's latest post:
Provectus Pharmaceuticals Inc.
Published (2009-07-08 18:06:00)
The company gives the impression that the liver and psoriasis trials are mostly fully funded. The Phase III melanoma trial would certainly be expensive though. They would almost certainly need some sort of partnership with a blue chip pharma firm and/or licensing of PH-10 to make that work.
user's latest post:
biotech firesales
Published (2009-07-08 12:49:00)
"Shares of Aryx Therapeutics were pummeled in premarket trading after the company announced that its trial comparing the experimental blood clotting drug tecarfarin failed to demonstrate superiority over warfarin, a standard treatment. The data was positive for both treatments. Tecarfarin stayed in its target therapeutic range 74 percent of the time while warfarin hit a nearly identical 73.2 percent mark. That's not what...
user's latest post:
Biotech Valuation
Published (2009-07-08 14:24:00)
This is interesting: Letter Nature advance online publication 8 July 2009 | doi:10.1038/nature08221; Received 9 April 2009; Accepted 24 June 2009; Published online 8 July 2009 Rapamycin fed late in life extends lifespan in genetically heterogeneous mice David E. Harrison1,11, Randy Strong2,11, Zelton Dave Sharp3, James F. Nelson4, Clinton M. Astle1, Kevin Flurkey1, Nancy L. Nadon5, J. Erby Wilkinson6, Krystyna Frenkel7, Christy S. Carter8,...
|
|
|
|
Latest active threads on Biotechnology::
Started 7 hours, 39 minutes ago (2009-07-09 22:57:00)
by Biomaven
>>definition of a junk bio? My definition of a junk bio is a company that either has no reasonable prospect of getting a drug to market (like MSHL) or one whose principle line of business is selling stock (like CTIC). Not sure what Drew's definition of a scam biotech is, but I'm guessing it's something along the lines of my second category. Peter
Started 11 hours, 12 minutes ago (2009-07-09 19:24:00)
by John Metcalf
PIMCO made a statement that they had withdrawn their application in early June, due to "uncertainties" in design of PPIP. http://dealbook.blogs.nytimes.com/2009/07/08/treas ury-picks-nine-firms-for-toxic-securities-plan/ PPIP conflict of interest guidelines are here: http://www.financialstability.gov/docs/PPIP_Confli ct-of-Interest-Rules.pdf The first standard is that a management ...
Started 11 hours, 21 minutes ago (2009-07-09 19:15:00)
by ewolf
What is the definition of a junk bio? Is it different than Dew's scam bio?
Started 12 hours, 28 minutes ago (2009-07-09 18:08:00)
by TexasDude
WAG? Only if you are a cute puppy or good bird dog! My guess is the conflict issue.
Started 12 hours, 33 minutes ago (2009-07-09 18:03:00)
by IRWIN JAMES FRANKEL
>>. Pimco wasn't one of the firms. What do you read into this issue.........did Gross get 'cold-feet'? Not a chance. If I were to make a WAG*, I would guess that the government either excluded them for some conflict, or they had to elect whether to participate or drop some consulting they were already doing for the government or the FRB. ij Are we allowed to WAG here? :-)
Started 12 hours, 37 minutes ago (2009-07-09 17:59:00)
by TexasDude
IJ, When the Treasury Dept announced the program for financial firms to buy banks' bad mortgage-related investments(PPIP), Bill Gross immediately supported the program with statements that Pimco would participate in the program. However, with the announcement yesterday that 9 firms had been selected....Pimco wasn't one of the firms. What do you read into this issue.........did Gross get '...
Started 12 hours, 41 minutes ago (2009-07-09 17:55:00)
by TexasDude
Dew, Good question about the direction of the train movement, however, I didn't make a mental note of that issue so I can't answer definitively. I do remember that the Wyoming coal cars were eastward bound, but then we were headed south on the extreme eastern side of the state....Sheridan to Cheyenne. I do remember the one long train that was carrying finished goods was moving westward......
Started 13 hours, 32 minutes ago (2009-07-09 17:04:00)
by DewDiligence_on_SI
>Other companies have similar compounds further in development to prevent or treat potentially life-threatening clots in heart and surgery patients. Boehringer Ingelheim GmbH's dabigatran anticoagulant is on the market in Europe for clot prevention after hip- and knee-replacement surgery, and data are expected soon from a large trial in heart patients with atrial fibrillation. ...
Started 15 hours, 37 minutes ago (2009-07-09 14:59:00)
by Ian@SI
* JULY 9, 2009, 11:15 A.M. ET Merck Acquires Rights to Anticoagulant Merck & Co. on Thursday said it has obtained world-wide rights to co-develop and commercialize an experimental drug in a crowded race to replace the anticoagulant warfarin, one of the oldest pills in medicine. The Whitehouse Station, N.J., drug company will pay closely held Portola Inc., of South San Francisco,...
Started 16 hours, 51 minutes ago (2009-07-09 13:45:00)
by me otter
On 5/27 I paid $2.46 for IMMU. On 5/27 the SPY was trading at 92ish. Today IMMU traded at $2.46 and the SPY traded 88ish. I hope we can continue to outperform...mind you or volatility is WAY bigger than that of SPY. I guess I'm most impressed by how well we have held up with the lack of news. ( eh? )
|
|
Hot threads for last week on Biotechnology::
Started 1 week, 2 days ago (2009-07-01 04:03:00)
by idos
FDA panel recommends smaller doses of painkillers http://news.yahoo.com/s/ap/20090630/ap_on_he_me/us _tylenol_safety_fda By MATTHEW PERRONE, AP Business Writer Matthew Perrone, Ap Business Writer Tue Jun 30, 3:46 pm ET ADELPHI, Md. – Government experts say prescription drugs like Vicodin and Percocet that combine a popular painkiller with stronger narcotics should be eliminated ...
Started 1 week, 1 day ago (2009-07-01 18:52:00)
by Mammon
It probably cures gingivitis, too. About MRSA: [from the january 09 stockholder letter]: "In May Provectus Began a Phase 2 Clinical Trial of PH-10, a Topical Formulation of Rose Bengal for Dermatology, for Atopic Dermatitis. The study is evaluating safety and efficacy of PH-10 in a total of twenty subjects with mild to severe forms of the disease. The daily application of the drug in ...
Started 1 week, 1 day ago (2009-07-01 17:48:00)
by Mark Buczynski
Started 1 week, 1 day ago (2009-07-01 17:46:00)
by prnz
Care to disclose anything you've heard regarding PH-10?
Started 1 week, 1 day ago (2009-07-01 17:40:00)
by Mark Buczynski
Started 1 week, 1 day ago (2009-07-01 17:34:00)
by Bradpalm1
Do you mean PH-10 for MRSA?
Started 1 week, 1 day ago (2009-07-01 16:56:00)
by Mark Buczynski
I realized that I never responded. No studies that I know of. Actually none needed at this time. 1 - almost all areas of the body are accessible for a PV-10 injection into a tumor. 2- when injected into a tumor, it elicits an immune response (bystander effect) that will eradicate all other tumors that have metastasized from that tumor. Laymen will call this a vaccine. 3 - all of the ...
Started 1 week, 1 day ago (2009-07-01 09:40:00)
by prnz
Judging from the info on ClinicalTrials.Gov I'm guessing we should see something by the end of August.
Started 1 week, 1 day ago (2009-07-01 08:06:00)
by JUNIORB
Well now we are getting somewhere. Great announcement this morning. I hope we don't break into the .90 range. (just kiddin) When will we see actual hardcore results of these 20 patients. Hopefully a partnership will emerge shortly. Still keepin the faith. JR.
Started 1 week, 1 day ago (2009-07-01 07:53:00)
by Howard Williams
PROVECTUS PHARMACEUTICALS COMPLETES PATIENT ACCRUAL IN INITIAL PHASE 2 STUDY OF PH-10 FOR ATOPIC DERMATITIS Tuesday July 1, 2009 --Preliminary Analyses Highlight Safety and Efficacy-- --Triggers Milestone to Seek Licensing Partner or Co-Developer for Product-- KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage ...
|
|